期刊文献+

即时检测芯片通道表面亲水涂膜处理工艺

Hydrophilic coating treatment process on channel surface of POCT chips
下载PDF
导出
摘要 聚合物即时检测(POCT)芯片通道自身表面张力不足,液体在通道中前进会造成前端流动形状不稳定,或引起断流现象,严重影响检测结果。设计并制作即时检测芯片,利用二氧化钛(Ti O_2)亲水浸渍提拉涂膜的方法对芯片通道进行改性研究。研究结果显示,亲水涂层使材料表面羟基含量提高,增强了其亲水性;亲水涂覆后,液体在芯片通道中流动形状与流动速度稳定;亲水膜表面成膜质量较好,成膜厚度在百纳米级,不会影响通道微结构; c Tn I荧光检测峰值稳定。 Because of the weakness of surface tension in channel of polymer microfluidic chip,the unstable flow shape of liquid front-end will occur,even cause cut off which will seriously affect the results of test.A POCT chip is designed and fabricated,and hydrophilic coating of TiO2 method is used to solve the problem.Research result shows that the hydrophilic coating improves the hydroxyl content and enhances hydrophilicity of the material.And the liquid has stable flow shape and velocity in channel of chip after hydrophilic coating.In addition,the hydrophilic film has good quality,and the film thickness can reach the hundred nanometers level which will not affect the microstructures in the channel,and the peak value of cTnI fluorescence detection is stable.
作者 李霞 刘冲 梁超 李经民 LI Xia;LIU Chong;LIANG Chao;LI Jing-min(School of Mechanical Engineering,Dalian University of Technology,Dalian 116024,China;Key Laboratory for Micro/Nano Technology and System of Liaoning Province,Dalian University of Technology,Dalian 116024,China)
出处 《传感器与微系统》 CSCD 2019年第3期17-20,27,共5页 Transducer and Microsystem Technologies
基金 国家自然科学基金面上资助项目(51375076)
关键词 微流控芯片 即时检测 纳米涂膜 荧光检测 microfluidic chips point-of-care testing(POCT) nano coating fluorescence detection
  • 相关文献

参考文献6

二级参考文献126

  • 1陶义训.POCT——检验医学的新领域[J].医学检验与临床,2002,14(3):4-5. 被引量:2
  • 2胡勤辛,叶雄伟,毕其华.20台POCT血糖仪对照试验及现状调查分析[J].实用糖尿病杂志,2005,13(1):21-23. 被引量:22
  • 3CURTIS A, LORI M, PETER J. Improving anticoagulation therapy using point - of - care testing and a standardized protocol [ J ]. Annals of family medicine,2008,6( 1 ) :s28 - s32.
  • 4Stacy EF.What's new in point of care testing? Point of Care,2008,7(1):38-39.
  • 5Barbara MG,Eleanor MT,Lawrence SL,et al.Point-of-care in vitro diagnostic (IVD) testing:proposed guideline.CLSI AST2-A,1999,19(9):1-9.
  • 6Carlson DA.Point of care testing:regulation and accreditation.Clin Lab Sci,1996,9(5):298-302.
  • 7Apple FS,Ler R,Chung AY,et al.Point-of-care i-STAT cardiac troponin I for assessment of patients with symptoms suggestive of acute coronary syndrome.Clin Chem,2006,52(2):322-325.
  • 8Di Serio F,Lovero R,Leone M,et al.Integration between the tele-cardiology unit and the central laboratory:methodological and clinical evaluation of point-of-care testing cardiac marker in the ambulance.Clin Chem Lab Med,2006,44(6):768-773.
  • 9Maeder MT,Christian M,Matthias EP,et al.Use of B-type natriuretic peptide outside of the emergency department.International Journal of Cardiology,2008,127(1):5-16.
  • 10Wehmeier M,Arndt BT,Schumann G,et al.Evaluation and quality assessment of glucose concentration measurement in blood by point-of-care testing devices.Clin Chem Lab Med,2006,44(7):888-893.

共引文献118

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部